Tehran University of Medical Sciences

Science Communicator Platform

Share By
Will Nanotechnology Bring New Hope for Gene Delivery? Publisher Pubmed



Wong JKL1 ; Mohseni R2 ; Hamidieh AA2 ; Maclaren RE3 ; Habib N4 ; Seifalian AM5
Authors

Source: Trends in Biotechnology Published:2017


Abstract

The high mortality rates of cancer patients receiving standard treatments emphasize the crucial need for alternative treatments. One promising strategy is to use organic nanoparticles (NPs) for gene delivery. Although multifunctional NPs theoretically have many desirable properties as gene vectors, there are several practical barriers to successful gene delivery. In this review we discuss the properties of NPs and overview in vitro and preclinical studies of organic NPs over the past 5 years. The results of recent clinical trials suggest that the NP field holds significant promise. The annual market value for successful gene delivery could exceed US$30 billion, and this will encourage researchers to study the application of NPs to therapeutic gene delivery. © 2016 Elsevier Ltd
Related Docs
View other Related Docs
1. Emerging Innovations in Vincristine-Encapsulated Nanoparticles: Pioneering a New Era in Oncological Therapeutics, Journal of Drug Delivery Science and Technology (2024)
2. A Review of Dna Nanoparticles-Encapsulated Drug/Gene/Protein for Advanced Controlled Drug Release: Current Status and Future Perspective Over Emerging Therapy Approaches, International Journal of Biological Macromolecules (2024)
3. Toxicity of Inorganic Nanoparticles, Comprehensive Analytical Chemistry (2022)
Experts (# of related papers)
View all Related Experts
Fatemeh Atyabi (2)
Seyed Mojtaba Daghighi (1)
Other Related Docs
4. The Quest for a Better Fight: How Can Nanomaterials Address the Current Therapeutic and Diagnostic Obstacles in the Fight Against Covid-19?, Journal of Drug Delivery Science and Technology (2022)
5. Metallic Nanoparticles for the Modulation of Tumor Microenvironment; a New Horizon, Frontiers in Bioengineering and Biotechnology (2022)
6. Unveiling the Hidden Risks of Human Exposure to Nanomedicine and Nanopollutants: Nanoparticle-Induced Blood Barrier Disruption and Tissue Toxicity, Colloids and Surfaces B: Biointerfaces (2025)
7. Does Pharmacodynamics of Drugs Change After Presenting Them As Na-Noparticles Like Their Pharmacokinetics?, Current Drug Targets (2020)
8. Advances in Nanomedicine-Based Retinal Drug Delivery: Mechanisms and Translational Applications, Journal of Nanobiotechnology (2026)
9. Triple-Negative Breast Cancer Treatment Meets Nanoparticles: Current Status and Future Direction, Journal of Drug Delivery Science and Technology (2022)
10. Nanoparticles As New Tools for Inhibition of Cancer Angiogenesis, Journal of Cellular Physiology (2018)
11. Micelle-Based Nanoparticles With Stimuli-Responsive Properties for Drug Delivery, Nanotechnology Reviews (2024)
12. Nano-Particles’ Benefits for Colon Cancer Effective Therapy: A Review of Recent Advancements and Clinical Trials, International Journal of Polymeric Materials and Polymeric Biomaterials (2024)
13. Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and Igf-1R Sirna to Skbr3 Metastatic Breast Cancer Cells, Iranian Biomedical Journal (2019)